Vipin K. Garg Ph.D.
Net Worth

Last updated:

What is Vipin K. Garg Ph.D. net worth?

The estimated net worth of Dr. Vipin K. Garg Ph.D. is at least $6,864,874 as of 2 Feb 2024. He owns shares worth $852,469 as insider, has earned $626,205 from insider trading and has received compensation worth at least $5,386,200 in Altimmune, Inc..

What is the salary of Vipin K. Garg Ph.D.?

Dr. Vipin K. Garg Ph.D. salary is $897,700 per year as Pres, Chief Executive Officer & Director in Altimmune, Inc..

How old is Vipin K. Garg Ph.D.?

Dr. Vipin K. Garg Ph.D. is 67 years old, born in 1958.

What stocks does Vipin K. Garg Ph.D. currently own?

As insider, Dr. Vipin K. Garg Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Altimmune, Inc. (ALT) Pres, Chief Executive Officer & Director 236,797 $3.6 $852,469

What does Altimmune, Inc. do?

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

ALT logo
ALT
Altimmune, Inc.
$3.6

Vipin K. Garg Ph.D. insider trading

Altimmune, Inc.

Dr. Vipin K. Garg Ph.D. has made 2 insider trades between 2019-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 26,775 units of ALT stock on 30 Jan 2024. As of 2 Feb 2024 he still owns at least 236,797 units of ALT stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 18,950 N/A N/A
Option
Common Stock, par value $0.0001 18,950 N/A N/A
Option
Restricted Stock Units 16,545 N/A N/A
Option
Common Stock, par value $0.0001 16,545 N/A N/A
Option
Common Stock, par value $0.0001 26,775 N/A N/A
Option
Restricted Stock Units 26,775 N/A N/A
Option
Common Stock, par value $0.0001 18,950 N/A N/A
Option
Restricted Stock Units 18,950 N/A N/A
Option
Restricted Stock Units 16,546 N/A N/A
Option
Common Stock, par value $0.0001 16,546 N/A N/A
Sale
Common Stock, par value $0.0001 20,000 $20.02 $400,320
Sale
Common Stock, par value $0.0001 15,000 $15.06 $225,885
Option
Restricted Stock Units 16,545 N/A N/A
Option
Common Stock, par value $0.0001 16,545 N/A N/A
Purchase
Common Stock, par value $0.0001 20,000 $2.1 $42,000

Altimmune key executives

Altimmune, Inc. executives and other stock owners filed with the SEC: